Yara Abdou, MD, an assistant professor in the Division of Oncology published a聽 with聽Norman E. Sharpless, MD. They responded to a new聽 that found enrollment in industry-sponsored cancer clinical trials doubled between 2008 and 2022 while federally supported trial enrollment remained flat. From 2018 to 2022, cancer clinical trial enrollment was eight times greater in industry-sponsored studies compared to federal studies.